kras mutation and glutathion glynac Treatment of KRAS-Mutated Pancreatic Cancer: New Hope for the Patients? Multiple Strategies to Develop Small
Multiple Strategies to Develop Small Molecular KRAS Directly Bound Inhibitors Oncometabolites in pancreatic cancer: Strategies and its implications PMC The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy PMC Metabolic reprogramming in KRAS mutant cancers: Proven targetable vulnerabilities and potential therapeutic strategies ScienceDirect Isoform Specific Destabilization of the Active Site Reveals a Molecular Mechanism of Intrinsic Activation of KRas G13D: Cell Reports Mutant KRas Induced Mitochondrial Oxidative Stress in Acinar Cells Upregulates EGFR Signaling to Drive Formation of Pancreatic Precancerous Lesions ScienceDirect
Pay in 4 interest-free payments of $5.52 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5





